E
VentriPoint Diagnostics Ltd.
VPTDF
$0.123
$0.021821.54%
E
Sell
11/4/2024Downgrade
VentriPoint Diagnostics Ltd. (VPTDF) was downgraded to E+ from D- on 11/4/2024 due to a decline in the total return index and volatility index.
VentriPoint Diagnostics Ltd. (VPTDF) was downgraded to E+ from D- on 11/4/2024 due to a decline in the total return index and volatility index.
D
Sell
10/18/2024Upgraded
VentriPoint Diagnostics Ltd. (VPTDF) was upgraded to D- from E+ on 10/18/2024 due to an increase in the volatility index and valuation index.
VentriPoint Diagnostics Ltd. (VPTDF) was upgraded to D- from E+ on 10/18/2024 due to an increase in the volatility index and valuation index.
E
Sell
9/30/2024Downgrade
VentriPoint Diagnostics Ltd. (VPTDF) was downgraded to E+ from D- on 9/30/2024 due to a significant decline in the solvency index, growth index and total return index. The quick ratio declined from 0.39 to 0.27, operating cash flow declined 24.22% from -$647.7 to -$804.6, and earnings per share declined from -$0.0056 to -$0.0066.
VentriPoint Diagnostics Ltd. (VPTDF) was downgraded to E+ from D- on 9/30/2024 due to a significant decline in the solvency index, growth index and total return index. The quick ratio declined from 0.39 to 0.27, operating cash flow declined 24.22% from -$647.7 to -$804.6, and earnings per share declined from -$0.0056 to -$0.0066.
D
Sell
8/8/2024Upgraded
VentriPoint Diagnostics Ltd. (VPTDF) was upgraded to D- from E+ on 8/8/2024 due to an increase in the valuation index and growth index. Operating cash flow increased 11.15% from -$729 to -$647.7, EBIT increased 4.58% from -$912.2 to -$870.4, and earnings per share increased from -$0.0058 to -$0.0056.
VentriPoint Diagnostics Ltd. (VPTDF) was upgraded to D- from E+ on 8/8/2024 due to an increase in the valuation index and growth index. Operating cash flow increased 11.15% from -$729 to -$647.7, EBIT increased 4.58% from -$912.2 to -$870.4, and earnings per share increased from -$0.0058 to -$0.0056.
E
Sell
4/11/2024Downgrade
VentriPoint Diagnostics Ltd. (VPTDF) was downgraded to E+ from D- on 4/11/2024 due to a decline in the total return index and volatility index.
VentriPoint Diagnostics Ltd. (VPTDF) was downgraded to E+ from D- on 4/11/2024 due to a decline in the total return index and volatility index.
D
Sell
2/23/2024Upgraded
VentriPoint Diagnostics Ltd. (VPTDF) was upgraded to D- from E+ on 2/23/2024 due to an increase in the volatility index.
VentriPoint Diagnostics Ltd. (VPTDF) was upgraded to D- from E+ on 2/23/2024 due to an increase in the volatility index.
E
Sell
2/8/2024Downgrade
VentriPoint Diagnostics Ltd. (VPTDF) was downgraded to E+ from D- on 2/8/2024 due to a decline in the solvency index, valuation index and volatility index. Debt to equity increased from 0.08 to 0.15, and the quick ratio declined from 3.03 to 2.
VentriPoint Diagnostics Ltd. (VPTDF) was downgraded to E+ from D- on 2/8/2024 due to a decline in the solvency index, valuation index and volatility index. Debt to equity increased from 0.08 to 0.15, and the quick ratio declined from 3.03 to 2.
D
Sell
7/17/2023Upgraded
VentriPoint Diagnostics Ltd. (VPTDF) was upgraded to D- from E+ on 7/17/2023 due to an increase in the volatility index.
VentriPoint Diagnostics Ltd. (VPTDF) was upgraded to D- from E+ on 7/17/2023 due to an increase in the volatility index.
E
Sell
5/15/2023Downgrade
VentriPoint Diagnostics Ltd. (VPTDF) was downgraded to E+ from D- on 5/15/2023 due to a decline in the solvency index, total return index and volatility index. Debt to equity increased from 0.03 to 0.04, and the quick ratio declined from 6.34 to 5.27.
VentriPoint Diagnostics Ltd. (VPTDF) was downgraded to E+ from D- on 5/15/2023 due to a decline in the solvency index, total return index and volatility index. Debt to equity increased from 0.03 to 0.04, and the quick ratio declined from 6.34 to 5.27.
D
Sell
4/25/2023Upgraded
VentriPoint Diagnostics Ltd. (VPTDF) was upgraded to D- from E+ on 4/25/2023 due to an increase in the valuation index.
VentriPoint Diagnostics Ltd. (VPTDF) was upgraded to D- from E+ on 4/25/2023 due to an increase in the valuation index.
E
Sell
3/14/2023Downgrade
VentriPoint Diagnostics Ltd. (VPTDF) was downgraded to E+ from D on 3/14/2023 due to a decline in the total return index and volatility index.
VentriPoint Diagnostics Ltd. (VPTDF) was downgraded to E+ from D on 3/14/2023 due to a decline in the total return index and volatility index.
D
Sell
2/23/2023Upgraded
VentriPoint Diagnostics Ltd. (VPTDF) was upgraded to D from D- on 2/23/2023 due to an increase in the total return index and volatility index.
VentriPoint Diagnostics Ltd. (VPTDF) was upgraded to D from D- on 2/23/2023 due to an increase in the total return index and volatility index.
D
Sell
2/8/2023Downgrade
VentriPoint Diagnostics Ltd. (VPTDF) was downgraded to D- from D on 2/8/2023 due to a decline in the valuation index.
VentriPoint Diagnostics Ltd. (VPTDF) was downgraded to D- from D on 2/8/2023 due to a decline in the valuation index.
D
Sell
5/16/2022Upgraded
VentriPoint Diagnostics Ltd. (VPTDF) was upgraded to D from E+ on 05/16/2022.
VentriPoint Diagnostics Ltd. (VPTDF) was upgraded to D from E+ on 05/16/2022.
E
Sell
5/13/2022Downgrade
VentriPoint Diagnostics Ltd. (VPTDF) was downgraded to E+ from D on 5/13/2022 due to a decline in the total return index.
VentriPoint Diagnostics Ltd. (VPTDF) was downgraded to E+ from D on 5/13/2022 due to a decline in the total return index.
D
Sell
5/4/2022Upgraded
VentriPoint Diagnostics Ltd. (VPTDF) was upgraded to D from E+ on 5/4/2022 due to an increase in the solvency index and valuation index. The quick ratio increased from 2.52 to 8.72, and debt to equity declined from 0.11 to 0.02.
VentriPoint Diagnostics Ltd. (VPTDF) was upgraded to D from E+ on 5/4/2022 due to an increase in the solvency index and valuation index. The quick ratio increased from 2.52 to 8.72, and debt to equity declined from 0.11 to 0.02.
E
Sell
5/1/2022Downgrade
VentriPoint Diagnostics Ltd. (VPTDF) was downgraded to E+ from D on 5/1/2022 due to a decline in the total return index.
VentriPoint Diagnostics Ltd. (VPTDF) was downgraded to E+ from D on 5/1/2022 due to a decline in the total return index.
D
Sell
4/21/2022Upgraded
VentriPoint Diagnostics Ltd. (VPTDF) was upgraded to D from E+ on 04/21/2022.
VentriPoint Diagnostics Ltd. (VPTDF) was upgraded to D from E+ on 04/21/2022.
E
Sell
4/20/2022Downgrade
VentriPoint Diagnostics Ltd. (VPTDF) was downgraded to E+ from D on 4/20/2022 due to a significant decline in the total return index, growth index and volatility index. Earnings per share declined from -$0.0032 to -$0.0042.
VentriPoint Diagnostics Ltd. (VPTDF) was downgraded to E+ from D on 4/20/2022 due to a significant decline in the total return index, growth index and volatility index. Earnings per share declined from -$0.0032 to -$0.0042.
D
Sell
11/9/2021Upgraded
VentriPoint Diagnostics Ltd. (VPTDF) was upgraded to D from E+ on 11/9/2021 due to an increase in the valuation index.
VentriPoint Diagnostics Ltd. (VPTDF) was upgraded to D from E+ on 11/9/2021 due to an increase in the valuation index.
E
Sell
11/8/2021Downgrade
VentriPoint Diagnostics Ltd. (VPTDF) was downgraded to E+ from D on 11/8/2021 due to a decline in the valuation index.
VentriPoint Diagnostics Ltd. (VPTDF) was downgraded to E+ from D on 11/8/2021 due to a decline in the valuation index.
D
Sell
12/17/2020Upgraded
VentriPoint Diagnostics Ltd. (VPTDF) was upgraded to D from D- on 12/17/2020 due to an increase in the total return index.
VentriPoint Diagnostics Ltd. (VPTDF) was upgraded to D from D- on 12/17/2020 due to an increase in the total return index.
D
Sell
12/2/2020Downgrade
VentriPoint Diagnostics Ltd. (VPTDF) was downgraded to D- from D on 12/2/2020 due to a large decline in the growth index and valuation index. Earnings per share declined from -$0.0032 to -$0.0075, and EBIT declined 84.99% from -$231.9 to -$429.
VentriPoint Diagnostics Ltd. (VPTDF) was downgraded to D- from D on 12/2/2020 due to a large decline in the growth index and valuation index. Earnings per share declined from -$0.0032 to -$0.0075, and EBIT declined 84.99% from -$231.9 to -$429.
D
Sell
9/25/2020Upgraded
VentriPoint Diagnostics Ltd. (VPTDF) was upgraded to D from D- on 9/25/2020 due to a noticeable increase in the volatility index and growth index. Earnings per share increased from -$0.0086 to -$0.0032, operating cash flow increased 28.39% from -$207.5 to -$148.6, and EBIT increased 11.01% from -$260.6 to -$231.9.
VentriPoint Diagnostics Ltd. (VPTDF) was upgraded to D from D- on 9/25/2020 due to a noticeable increase in the volatility index and growth index. Earnings per share increased from -$0.0086 to -$0.0032, operating cash flow increased 28.39% from -$207.5 to -$148.6, and EBIT increased 11.01% from -$260.6 to -$231.9.
D
Sell
6/11/2020Upgraded
VentriPoint Diagnostics Ltd. (VPTDF) was upgraded to D- from E+ on 6/11/2020 due to an increase in the growth index and volatility index.
VentriPoint Diagnostics Ltd. (VPTDF) was upgraded to D- from E+ on 6/11/2020 due to an increase in the growth index and volatility index.
E
Sell
5/8/2020Downgrade
VentriPoint Diagnostics Ltd. (VPTDF) was downgraded to E+ from D- on 5/8/2020 due to a decline in the total return index and volatility index.
VentriPoint Diagnostics Ltd. (VPTDF) was downgraded to E+ from D- on 5/8/2020 due to a decline in the total return index and volatility index.
D
Sell
5/1/2020Downgrade
VentriPoint Diagnostics Ltd. (VPTDF) was downgraded to D- from D on 5/1/2020 due to a significant decline in the efficiency index, solvency index and growth index. Operating cash flow declined 729.37% from -$89.9 to -$745.6, the quick ratio declined from 0.09 to 0.04, and net income declined 14.08% from -$411.3 to -$469.2.
VentriPoint Diagnostics Ltd. (VPTDF) was downgraded to D- from D on 5/1/2020 due to a significant decline in the efficiency index, solvency index and growth index. Operating cash flow declined 729.37% from -$89.9 to -$745.6, the quick ratio declined from 0.09 to 0.04, and net income declined 14.08% from -$411.3 to -$469.2.
D
Sell
1/28/2020Downgrade
VentriPoint Diagnostics Ltd. (VPTDF) was downgraded to D from D+ on 1/28/2020 due to a decline in the total return index and volatility index.
VentriPoint Diagnostics Ltd. (VPTDF) was downgraded to D from D+ on 1/28/2020 due to a decline in the total return index and volatility index.
D
Sell
1/13/2020Upgraded
VentriPoint Diagnostics Ltd. (VPTDF) was upgraded to D+ from D on 1/13/2020 due to an increase in the total return index and volatility index.
VentriPoint Diagnostics Ltd. (VPTDF) was upgraded to D+ from D on 1/13/2020 due to an increase in the total return index and volatility index.
D
Sell
12/27/2019Downgrade
VentriPoint Diagnostics Ltd. (VPTDF) was downgraded to D from D+ on 12/27/2019 due to a decline in the total return index, volatility index and solvency index. The quick ratio declined from 0.16 to 0.09, and debt to equity increased from -0.37 to -0.29.
VentriPoint Diagnostics Ltd. (VPTDF) was downgraded to D from D+ on 12/27/2019 due to a decline in the total return index, volatility index and solvency index. The quick ratio declined from 0.16 to 0.09, and debt to equity increased from -0.37 to -0.29.
D
Sell
8/30/2019Upgraded
VentriPoint Diagnostics Ltd. (VPTDF) was upgraded to D+ from D on 8/30/2019 due to a major increase in the growth index. Earnings per share increased from -$0.0162 to -$0.0075, operating cash flow increased 45.32% from -$620.3 to -$339.2, and EBIT increased 15.79% from -$779.5 to -$656.4.
VentriPoint Diagnostics Ltd. (VPTDF) was upgraded to D+ from D on 8/30/2019 due to a major increase in the growth index. Earnings per share increased from -$0.0162 to -$0.0075, operating cash flow increased 45.32% from -$620.3 to -$339.2, and EBIT increased 15.79% from -$779.5 to -$656.4.
D
Sell
8/28/2019Downgrade
VentriPoint Diagnostics Ltd. (VPTDF) was downgraded to D from D+ on 8/28/2019 due to a decline in the volatility index.
VentriPoint Diagnostics Ltd. (VPTDF) was downgraded to D from D+ on 8/28/2019 due to a decline in the volatility index.
D
Sell
7/5/2019Upgraded
VentriPoint Diagnostics Ltd. (VPTDF) was upgraded to D+ from D on 7/5/2019 due to an increase in the total return index and volatility index.
VentriPoint Diagnostics Ltd. (VPTDF) was upgraded to D+ from D on 7/5/2019 due to an increase in the total return index and volatility index.
D
Sell
5/31/2019Downgrade
VentriPoint Diagnostics Ltd. (VPTDF) was downgraded to D from D+ on 5/31/2019 due to a noticeable decline in the growth index, total return index and volatility index. Operating cash flow declined 33.6% from -$464.3 to -$620.3, earnings per share declined from -$0.0125 to -$0.015, and EBIT declined 9.07% from -$714.7 to -$779.5.
VentriPoint Diagnostics Ltd. (VPTDF) was downgraded to D from D+ on 5/31/2019 due to a noticeable decline in the growth index, total return index and volatility index. Operating cash flow declined 33.6% from -$464.3 to -$620.3, earnings per share declined from -$0.0125 to -$0.015, and EBIT declined 9.07% from -$714.7 to -$779.5.
D
Sell
5/1/2019Downgrade
VentriPoint Diagnostics Ltd. (VPTDF) was downgraded to D+ from C- on 5/1/2019 due to a decline in the growth index, solvency index and total return index. Earnings per share declined from -$0.0016 to -$0.0163, total revenue declined 100% from $46 to $0, and the quick ratio declined from 0.59 to 0.1.
VentriPoint Diagnostics Ltd. (VPTDF) was downgraded to D+ from C- on 5/1/2019 due to a decline in the growth index, solvency index and total return index. Earnings per share declined from -$0.0016 to -$0.0163, total revenue declined 100% from $46 to $0, and the quick ratio declined from 0.59 to 0.1.
C
Hold
3/29/2019Upgraded
VentriPoint Diagnostics Ltd. (VPTDF) was upgraded to C- from D+ on 3/29/2019 due to an increase in the volatility index and valuation index.
VentriPoint Diagnostics Ltd. (VPTDF) was upgraded to C- from D+ on 3/29/2019 due to an increase in the volatility index and valuation index.
D
Sell
3/14/2019Downgrade
VentriPoint Diagnostics Ltd. (VPTDF) was downgraded to D+ from C- on 3/14/2019 due to a decline in the total return index, volatility index and valuation index.
VentriPoint Diagnostics Ltd. (VPTDF) was downgraded to D+ from C- on 3/14/2019 due to a decline in the total return index, volatility index and valuation index.
C
Hold
11/30/2018Upgraded
VentriPoint Diagnostics Ltd. (VPTDF) was upgraded to C- from D+ on 11/30/2018 due to a noticeable increase in the growth index, efficiency index and valuation index. Earnings per share increased from -$0.0155 to -$0.0015, net income increased 87.74% from -$721.3 to -$88.4, and total capital increased 85.64% from -$906.9 to -$130.2.
VentriPoint Diagnostics Ltd. (VPTDF) was upgraded to C- from D+ on 11/30/2018 due to a noticeable increase in the growth index, efficiency index and valuation index. Earnings per share increased from -$0.0155 to -$0.0015, net income increased 87.74% from -$721.3 to -$88.4, and total capital increased 85.64% from -$906.9 to -$130.2.
D
Sell
9/18/2018Downgrade
VentriPoint Diagnostics Ltd. (VPTDF) was downgraded to D+ from C- on 9/18/2018 due to a decline in the total return index, volatility index and growth index. Earnings per share declined from -$0.0008 to -$0.0155, operating cash flow declined 21.7% from -$541.1 to -$658.5, and EBIT declined 20.21% from -$711.9 to -$855.8.
VentriPoint Diagnostics Ltd. (VPTDF) was downgraded to D+ from C- on 9/18/2018 due to a decline in the total return index, volatility index and growth index. Earnings per share declined from -$0.0008 to -$0.0155, operating cash flow declined 21.7% from -$541.1 to -$658.5, and EBIT declined 20.21% from -$711.9 to -$855.8.
C
Hold
6/15/2018Upgraded
VentriPoint Diagnostics Ltd. (VPTDF) was upgraded to C- from D on 6/15/2018 due to a significant increase in the efficiency index, growth index and volatility index. Net income increased 97.42% from -$1.54M to -$39.8, earnings per share increased from -$0.0299 to -$0.0008, and total capital increased 30.17% from -$1.3M to -$905.6.
VentriPoint Diagnostics Ltd. (VPTDF) was upgraded to C- from D on 6/15/2018 due to a significant increase in the efficiency index, growth index and volatility index. Net income increased 97.42% from -$1.54M to -$39.8, earnings per share increased from -$0.0299 to -$0.0008, and total capital increased 30.17% from -$1.3M to -$905.6.
D
Sell
12/1/2017Downgrade
VentriPoint Diagnostics Ltd. (VPTDF) was downgraded to D from C- on 12/1/2017 due to a significant decline in the efficiency index, growth index and total return index. Net income declined 88.43% from $1.38M to $159.2, earnings per share declined from $0.0297 to $0.0035, and EBIT declined 87.44% from -$502.3 to -$941.5.
VentriPoint Diagnostics Ltd. (VPTDF) was downgraded to D from C- on 12/1/2017 due to a significant decline in the efficiency index, growth index and total return index. Net income declined 88.43% from $1.38M to $159.2, earnings per share declined from $0.0297 to $0.0035, and EBIT declined 87.44% from -$502.3 to -$941.5.
C
Hold
6/5/2017Upgraded
VentriPoint Diagnostics Ltd. (VPTDF) was upgraded to C- from D+ on 6/5/2017 due to a significant increase in the efficiency index, total return index and valuation index.
VentriPoint Diagnostics Ltd. (VPTDF) was upgraded to C- from D+ on 6/5/2017 due to a significant increase in the efficiency index, total return index and valuation index.
D
Sell
5/12/2017Upgraded
VentriPoint Diagnostics Ltd. (VPTDF) was upgraded to D+ from D on 5/12/2017 due to a significant increase in the total return index, growth index and volatility index. Total revenue increased 6,400% from $2.3 to $149.5, earnings per share increased from -$0.023 to -$0.0179, and EBIT increased 9.31% from -$342.7 to -$310.8.
VentriPoint Diagnostics Ltd. (VPTDF) was upgraded to D+ from D on 5/12/2017 due to a significant increase in the total return index, growth index and volatility index. Total revenue increased 6,400% from $2.3 to $149.5, earnings per share increased from -$0.023 to -$0.0179, and EBIT increased 9.31% from -$342.7 to -$310.8.
D
Sell
3/2/2017Upgraded
VentriPoint Diagnostics Ltd. (VPTDF) was upgraded to D from D- on 3/2/2017 due to an increase in the volatility index and total return index.
VentriPoint Diagnostics Ltd. (VPTDF) was upgraded to D from D- on 3/2/2017 due to an increase in the volatility index and total return index.
D
Sell
12/1/2016Downgrade
VentriPoint Diagnostics Ltd. (VPTDF) was downgraded to D- from D on 12/1/2016 due to a large decline in the growth index. Total revenue declined 17.24% from $2.9 to $2.4.
VentriPoint Diagnostics Ltd. (VPTDF) was downgraded to D- from D on 12/1/2016 due to a large decline in the growth index. Total revenue declined 17.24% from $2.9 to $2.4.
D
Sell
3/11/2016Downgrade
VentriPoint Diagnostics Ltd. (VPTDF) was downgraded to D from D+ on 3/11/2016 due to a substantial decline in the volatility index and total return index.
VentriPoint Diagnostics Ltd. (VPTDF) was downgraded to D from D+ on 3/11/2016 due to a substantial decline in the volatility index and total return index.
D
Sell
12/21/2015Downgrade
VentriPoint Diagnostics Ltd. (VPTDD) was downgraded to D+ from C- on 12/21/2015 due to a substantial decline in the volatility index.
VentriPoint Diagnostics Ltd. (VPTDD) was downgraded to D+ from C- on 12/21/2015 due to a substantial decline in the volatility index.
C
Hold
12/4/2015Upgraded
VentriPoint Diagnostics Ltd. (VPTDF) was upgraded to C- from D on 12/4/2015 due to a substantial increase in the volatility index, growth index and valuation index.
VentriPoint Diagnostics Ltd. (VPTDF) was upgraded to C- from D on 12/4/2015 due to a substantial increase in the volatility index, growth index and valuation index.
D
Sell
12/1/2015Downgrade
VentriPoint Diagnostics Ltd. (VPTDF) was downgraded to D from C on 12/1/2015 due to a significant decline in the efficiency index, growth index and valuation index. Total capital declined 101.52% from -$1.35M to $20.5, total revenue declined 78.29% from $28.1 to $6.1, and net income declined 51.54% from -$543.8 to -$263.5.
VentriPoint Diagnostics Ltd. (VPTDF) was downgraded to D from C on 12/1/2015 due to a significant decline in the efficiency index, growth index and valuation index. Total capital declined 101.52% from -$1.35M to $20.5, total revenue declined 78.29% from $28.1 to $6.1, and net income declined 51.54% from -$543.8 to -$263.5.
C
Hold
5/1/2015Upgraded
VentriPoint Diagnostics Ltd. (VPTDF) was upgraded to C from C- on 5/1/2015 due to an increase in the growth index, valuation index and volatility index. EBIT increased 5.82% from -$520.4 to -$550.7.
VentriPoint Diagnostics Ltd. (VPTDF) was upgraded to C from C- on 5/1/2015 due to an increase in the growth index, valuation index and volatility index. EBIT increased 5.82% from -$520.4 to -$550.7.
C
Hold
12/3/2014Upgraded
VentriPoint Diagnostics Ltd. (VPTDF) was upgraded to C- from D+ on 12/3/2014 due to a significant increase in the efficiency index, growth index and solvency index. Total revenue increased 880.39% from $5.1 to $50, operating cash flow increased 159.15% from -$193.9 to -$502.5, and EBIT increased 44.72% from -$359.6 to -$520.4.
VentriPoint Diagnostics Ltd. (VPTDF) was upgraded to C- from D+ on 12/3/2014 due to a significant increase in the efficiency index, growth index and solvency index. Total revenue increased 880.39% from $5.1 to $50, operating cash flow increased 159.15% from -$193.9 to -$502.5, and EBIT increased 44.72% from -$359.6 to -$520.4.
D
Sell
9/5/2014Downgrade
VentriPoint Diagnostics Ltd. (VPTDF) was downgraded to D+ from C- on 9/5/2014 due to a significant decline in the efficiency index and valuation index. Total capital declined 2.82% from -$1.17M to -$1.14M.
VentriPoint Diagnostics Ltd. (VPTDF) was downgraded to D+ from C- on 9/5/2014 due to a significant decline in the efficiency index and valuation index. Total capital declined 2.82% from -$1.17M to -$1.14M.
OTC PK
03/12/2025 3:57PM Eastern
Quotes delayed
